
Summary for Tradename: XALATAN
|
|
Latest news for XALATANAMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice ...1 September 2010, 1:10 pm Research and Markets: Stakeholder Opinions: Ophthalmology - Leading Brands under Threat11 August 2010, 6:45 am PFIZER'S TOP 10 LEGACY DRUGS8 August 2010, 2:13 am Fight for Sight Announces 2010 Grant Winners for Promising Vision Research Studies4 August 2010, 10:16 am Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | XALATAN | latanoprost | 020597 | Jun 5, 1996 | RX | Yes | 5,296,504 | Y | Mar 22, 2011 | |||
| Pharmacia And Upjohn | XALATAN | latanoprost | 020597 | Jun 5, 1996 | RX | Yes | 5,422,368 | Y | Y | Mar 22, 2011 | ||
| Pharmacia And Upjohn | XALATAN | latanoprost | 020597 | Jun 5, 1996 | RX | Yes | 6,429,226 | Y | Sep 6, 2009 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.